General Knowledge MCQs
Topic Notes: General Knowledge
MCQs and preparation resources for competitive exams, covering important concepts, past papers, and detailed explanations.
Plato
- Biography: Ancient Greek philosopher (427–347 BCE), student of Socrates and teacher of Aristotle, founder of the Academy in Athens.
- Important Ideas:
- Theory of Forms
- Philosopher-King
- Ideal State
1
Which drug, approved in August 2025, targets HER2 tyrosine kinase domain mutations in non-small cell lung cancer?
Answer:
Hernexeos (zongertinib)
Hernexeos (zongertinib) was approved in August 2025 for adults with unresectable or metastatic non-squamous non-small cell lung cancer specifically harboring HER2 tyrosine kinase domain activating mutations.
2
Which company released the 'Llama' series of open-source language models, with significant updates in 2024 and 2025?
Answer:
Meta
Meta Platforms released the Llama series of models (including Llama 3 in 2024), which became a standard for open-source large language models in the AI community.
3
A November 2025 study on leukemia immunotherapy utilized which cell death mechanism to boost anti-tumor defenses?
Answer:
Necroptosis
The study found that inducing necroptosis, a form of programmed inflammatory cell death, in cancer cells could dramatically boost the body's immune attack against leukemia.
4
Which drug was approved in July 2025 to treat relapsed or refractory multiple myeloma?
Answer:
Lynozyfic (linvoseltamab)
Lynozyfic (linvoseltamab) was approved in July 2025 for treating adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy.
5
In November 2025, a new airflow device was introduced that can capture indoor germs almost immediately. Which university's engineers developed it?
Answer:
UBC Okanagan
Engineers at the University of British Columbia (UBC) Okanagan developed a new airflow device in November 2025 that traps exhaled aerosols and pathogens almost immediately to prevent disease spread indoors.
6
Which drug was approved in June 2025 for treating ROS1-positive non-small cell lung cancer?
Answer:
Ibtrozi (taletrectinib)
Ibtrozi (taletrectinib) received FDA approval in June 2025 for the treatment of patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.
7
Which term describes the 2025 robotics trend of robots made from pliable materials to handle delicate objects?
Answer:
Soft Robotics
Soft Robotics is a growing trend in 2025 involving the creation of robots from soft, flexible materials. This allows them to handle delicate items like fruit or electronics without damaging them.
8
Researchers in November 2025 found that Vitamin D3 supplementation could halve the risk of what event?
Answer:
Second heart attack
A study published in November 2025 indicated that Vitamin D3 supplementation could reduce the risk of suffering a second heart attack by approximately 50%.
9
What is the primary function of the drug 'Inluriyo' (imlunestrant), approved in September 2025?
Answer:
Treating breast cancer
Inluriyo (imlunestrant) was approved in September 2025 for the treatment of estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer.
10
Which AI tool released by OpenAI in late 2024 is capable of generating realistic video from text instructions?
Answer:
Sora
Sora is a text-to-video AI model released by OpenAI in December 2024 (publicly demoed earlier in the year) that can create realistic and imaginative scenes from text instructions.